Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This study will look at whether our drug (sorafenib) in combination with chemotherapy delivered directly into your tumor using beads (DC Bead) will slow the progression of the disease. The beads used with the chemotherapy will slowly release the chemotherapy reducing the adverse effects that normally occur with chemotherapy.
Full description
Safety issues will be reported in Adverse Event section. In addition to the secondary outcome measures, Biomarkers and Patient Report Outcome will also be analyzed as other variables.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For subjects without cirrhosis, histological or cytological confirmation is mandatory
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
307 participants in 2 patient groups, including a placebo group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal